drugset / Trial / NCT05451433
The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS
RandomizedParallel-groupTriple-blindTreatment
Summary
This study aims to compare the effectiveness of Saccharomyces Boulardii vs Placebo in patient with Irritable Bowel Syndrome
Timeline
- Start
- 2022-08-01
- Primary completion
- 2022-08-01
- Completion
- 2022-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Saccharomyces boulardii | Other / unclassified | 250 mg | — |